News

C3.AI Investors: Key Information on Class Action Lawsuit

C3.AI Investors: Key Information on Class Action Lawsuit

C3.ai Class Action Lawsuit Overview

The law firm of Robbins Geller Rudman & Dowd LLP has alerted investors of C3.ai, Inc. regarding a class action lawsuit. This lawsuit represents individuals who have acquired C3.ai (NYSE: AI) securities. The case is titled Liggett v. C3.ai, Inc., filed in a federal court.

Important Details for Investors

Those who have experienced significant losses in their investment in C3.ai now have a crucial opportunity to participate as lead plaintiffs in this lawsuit. If you are interested in taking an active role, it is essential to provide your information to the legal team.

How to Get Involved

Investors looking to stand as lead plaintiffs should take action promptly, as there are deadlines approaching for filing. Lead plaintiff motions must be submitted to the court by a specific date. Timing is critical in these legal proceedings, so if you believe you qualify, ensure you act quickly.

Understanding the Allegations

This class action lawsuit arises from allegations against C3.ai and certain executives regarding the dissemination of misleading information about the company's financial health and projections. According to the lawsuit, there were instances where C3.ai's leadership suggested they had a solid grasp on the company's revenue outlook, while hidden risks associated with the health issues of CEO Thomas M. Siebel were downplayed.

Impact on Stock Value

On August 8, 2025, C3.ai publicly announced disappointing preliminary financial results for the first quarter of fiscal year 2026. This announcement also included a downward revision of revenue guidance for the full fiscal year. The news, unfortunately, led to a significant drop of over 25% in the company's stock price.

The Role of a Lead Plaintiff

The Private Securities Litigation Reform Act of 1995 lays out the process for appointing a lead plaintiff. Any investor who purchased or acquired C3.ai shares during the designated Class Period has the right to seek this position. A lead plaintiff serves as a representative for the entire class, guiding the case forward and selecting a law firm to represent their collective interests.

About Robbins Geller

Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in representing investors in securities fraud and shareholder litigation matters. With a strong track record, the firm has secured substantial monetary relief for investors historically. Their experienced legal team has handled significant cases and enjoys a robust reputation for advocating for investor rights.

Contact Information

For further inquiries or assistance regarding the C3.ai class action lawsuit, investors can reach out to attorneys J.C. Sanchez or Jennifer N. Caringal from Robbins Geller. They can be contacted at the firm's office via phone or email for any questions or clarifications. Ensuring you are informed about your rights and options as an investor is crucial during this process.

Frequently Asked Questions

What is the C3.ai class action lawsuit about?

The class action lawsuit addresses allegations that C3.ai misled investors regarding financial forecasts and the health of its CEO.

How can I participate in the lawsuit?

If you suffered losses as an investor in C3.ai shares, you may participate by submitting your information to the law firm representing the lawsuit.

What are the potential outcomes of the class action?

The lawsuit could result in monetary relief for affected investors, depending on the court's findings.

What does being a lead plaintiff entail?

As a lead plaintiff, you represent the interests of all class members and guide the lawsuit's direction.

Why choose Robbins Geller for representation?

With a strong track record in securities litigation, Robbins Geller is equipped to effectively represent investors in complex cases.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

2026 CEE Awards Highlight Energy Innovation Leaders

Updated Category News Views 6

Showcasing Cutting-Edge Home Energy Innovations It's that time of year again when the brightest innovators in home energy solutions get a nod from the Consortium for Energy Efficiency (CEE). This year's Integrated Home Competition spotlighted five trailblazing products that promise to reshape how we think about energy efficiency, demand flexibility, and sheer user comfort...

Continue Reading
Medicare Competitive Bidding May Slash Jobs, Access

Updated Category News Views 4

Medicare's New Program: Potential Knockout Punch? Today, we dive into Medicare's latest shake-up that might just be the unseen wrecking ball swinging toward thousands of jobs and small businesses in the healthcare sector. Two years from now, starting January 2028, the Competitive Bidding Program is set to reroute the entire landscape for suppliers of key medical products...

Continue Reading
Solar Fencing Revolutionizes North Texas Homes

Updated Category News Views 4

Fences Go Solar: Welcome to the Future Land of fences and sunshine, North Texas is about to see a game changer in home improvement. Southwest Fence & Deck is rolling out the red carpet as an Authorized SOL Fence Installation Partner, putting solar power right in your backyard. Yeah, there have been sparks of innovation in plenty of fields, but who expected fences to join...

Continue Reading
Finastra Recognized as 2026 Leader in Payment Platforms

Updated Category News Views 4

Finastra Steals the Spotlight in Payments Innovation When it comes to the modern world of finance, nothing screams ‘adapt or fade into oblivion’ like the payments industry. Well, here’s a reality check from QKS Group: Finastra has snatched the spotlight in their SPARK Matrix™ for 2026 as a powerhouse in integrated bank payments platforms. Clearly, this ain’t...

Continue Reading
Goddess Maintenance Co. Eyes BeautyMatter Award

Updated Category News Views 5

Challenging the Haircare Norm with Confidence Goddess Maintenance Co. doesn't just draft a fresh play in the beauty industry playbook—it's ripping out the old pages and setting a new standard. This ain't your granny's haircare game anymore, folks. They're up for a 2026 BeautyMatter Award, a nod to their gut-busting innovation in the conditioner category with their star...

Continue Reading
Ransoms and Mega-Losses Surge in Cyber Claims Study

Updated Category News Views 5

Cyber Costs Skyrocket in Latest Study NetDiligence’s 2026 Cyber Claims Study isn't just another report—it’s a wake-up call. The numbers paint a stark picture: cyber incidents are burning deeper holes in pockets, and no one's immune. Whether you're a scrappy SME or a lumbering corporate giant, this report puts a magnifying glass to the chilling reality of cyber...

Continue Reading
Koogler's Sale to ALL4: A Game-Changer for the Southeast

Updated Category News Views 6

A Strategic Alignment Unfolds in Environmental Engineering Ever notice how those industry shifts often sneak up on you, only to leave a mark that's hard to ignore? That's exactly what's playing out with Koogler & Associates' recent hookup with ALL4 LLC. Set aside that coffee, this one's too important to miss if you've got a stake in the environmental consulting game or...

Continue Reading
American Savings Bank IPO Hits NYSE: $129M Raised

Updated Category News Views 6

A Big Day for American Savings Bank Buckled up yet? Because American Savings Bank has just shot onto the NYSE, raising a hefty $129 million. A solid start, I’d say, for a Honolulu-based outfit that now struts around with a valuation tipping beyond $1.03 billion. That’s what you get when you price more than eight million shares at $16 a pop. NYSE:ASBH is the new kid on...

Continue Reading
OrthoAtlanta Expands with Dr. Smith's Expertise Hire

Updated Category News Views 4

OrthoAtlanta Welcomes New Orthopedic Surgeon In a world where healthcare organizations are constantly stretching their wings, this new addition of Dr. Carson J. Smith to the fold at Piedmont Orthopedics | OrthoAtlanta stands out. This isn't just some cosmetic face-lift, folks. It's a real investment in the community, not to mention a crucial broadening of what this...

Continue Reading
Lyric Health's AI System Promises Data-Driven Revolution

Updated Category News Views 5

A Bold Step in Healthcare Coordination No doubt about it, healthcare is a mess. It's like trying to patch a leaking ship with duct tape—point solutions here, add-ons there, and nothing truly working in harmony. And in storms in Lyric Health, claiming they've got the answer. They've launched an AI-powered Healthcare Operating System meant to unify these disjointed pieces...

Continue Reading

Top 5 Most Recently Viewed Articles

Abeona Therapeutics Advances BLA Resubmission for Pz-cel

Updated Category News Views 197

Abeona Therapeutics Takes Important Steps Forward with Pz-cel Abeona Therapeutics Inc. has recently reached a significant milestone as the U.S. Food and Drug Administration (FDA) has accepted their Biologics License Application (BLA) resubmission for prademagene zamikeracel (pz-cel). This investigational autologous cell-based gene therapy aims to offer a promising new...

Continue Reading
Recent Trends and Insights into September 2024 Sales Prices

Updated Category News Views 161

Understanding Sales Price Trends for September 2024 The sales prices for September 2024 have shown a particularly interesting trend. Analyzing the group's pricing data reveals valuable insights into market dynamics over the quarters. A consistent evaluation over the years provides context for understanding the fluctuations in pricing. Quarterly Sales Prices Review...

Continue Reading
Workday Secures Prestigious Leader Spot in Latest Gartner Quadrant

Updated Category News Views 196

Workday Earns Leadership in Gartner Magic Quadrant Workday, Inc. (NASDAQ: WDAY), the premier enterprise AI platform for managing people, money, and processes, has proudly maintained its status as a leader in the financial planning software realm. For the fourth consecutive year, Workday has been recognized in the Magic Quadrant for Financial Planning Software published by...

Continue Reading
StoneX Group Inc. Partners in Record-Breaking Sales for Derby

Updated Category News Views 107

Record Ticket Sales for The Showdown 5 As anticipation builds for The Showdown 5, fans are thrilled to learn that the event has broken previous ticket sales records. With over 45,000 tickets sold already, enthusiasm surrounding the upcoming match between Saracens Rugby Club and Harlequins F.C. is palpable. This remarkable achievement occurs just weeks ahead of the event,...

Continue Reading
Navigating Market Waves: Strategies for Today’s Investors

Updated Category News Views 123

The Current State of the Market Recent trading has shown clear volatility, prevalent among investors and market watchers alike. Despite mixed signals, the S&P 500 continues on a bullish trajectory. There is still robust support ensuring that the market is not overbought, and money flows are significantly positive. This situation prompts a critical assessment of the...

Continue Reading